Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

January 15, 2007 (Vol. 27, No. 2)

Business Savvy for UK Biotechs

Genesis Conference Provides New Insights

  • Last month, the “London Biotechnology Network’s Sixth Annual Genesis Conference” took place amid concerns that too many U.K. biotechs are being bought out by their richer U.S. counterparts. Christopher Evans, DSc., founder of Merlin Biosciences, one of Europe’s largest specialist venture capital companies, directly addressed the issue. “Europe ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.